[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341535-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341535-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-pleiotropic-nature-of-nono-a-master-regulator-of-essential-biological-pathways-in-cancers","The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers","","NONO is a multifunctional DBHS family protein acting as a molecular scaffold in gene regulation and genome maintenance, influencing mRNA splicing, transcription activation and termination, DNA unwinding, nuclear retention of defective RNA, cell proliferation, apoptosis, migration, and DNA damage repair, and coupling the circadian rhythm to the cell cycle. Emerging evidence links altered NONO expression and modifications to tumorigenesis. This review integrates current mechanisms and highlights experimental caveats for studying NONO across tumor contexts, supporting its potential as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-pleiotropic-nature-of-nono-a-master-regulator-of-essential-biological-pathways-in-cancers/341535/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-pleiotropic-nature-of-nono-a-master-regulator-of-essential-biological-pathways-in-cancers/341535.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological functions does NONO regulate in cells?","Question",{"text":63,"@type":64},"NONO regulates diverse processes including gene regulation, cell proliferation, apoptosis, migration, and DNA damage repair. It also contributes to maintaining cellular circadian rhythm coupled to the cell cycle.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does NONO contribute to gene regulation at the molecular level?",{"text":68,"@type":64},"NONO participates in nearly every step of gene regulation, including mRNA splicing, transcription activation and termination, DNA unwinding, and nuclear retention of defective RNA. It binds both chromatin regulatory elements and intronic regions of pre-mRNAs.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is NONO considered relevant to cancer and therapeutic targeting?",{"text":72,"@type":64},"Altered NONO expression levels are associated with tumorigenesis, and NONO can be modified post-transcriptionally or post-translationally in ways whose cancer impact is still being clarified. The review proposes NONO as a potential therapeutic target while emphasizing caveats for experimental design and data interpretation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341535,1790178391,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www.nature.com/cgt](www.nature.com/cgt) Cancer Gene Therapy  \nREVIEW ARTICLE OPEN   \nThe pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers  \nDomenica Ronchetti 1, Valentina Traini 1, Ilaria Silvestris 1, Giuseppina Fabbiano2, Francesco Passamonti 1,2, Niccolò Bolli1,2 and Elisa Taiana 2 ✉  \n© The Author(s) 2024  \nNONO is a member of the Drosophila behavior/human splicing (DBHS) family of proteins. NONO is a multifunctional protein that acts as a “molecular scaffold” to carry out versatile biological activities in many aspects of gene regulation, cell proliferation, apoptosis, migration, DNA damage repair, and maintaining cellular circadian rhythm coupled to the cell cycle. Besides these physiological activities, emerging evidence strongly indicates that NONO-altered expression levels promote tumorigenesis. In addition, NONO can undergo various post-transcriptional or post-translational modiﬁcations, including alternative splicing, phosphorylation, methylation, and acetylation, whose impact on cancer remains largely to be elucidated. Overall, altered NONO expression and/or activities are a common feature in cancer. This review provides an integrated scenario of the current understanding of the molecular mechanisms and the biological processes affected by NONO in different tumor contexts, suggesting that a better elucidation of the pleiotropic functions of NONO in physiology and tumorigenesis will make it a potential therapeutic target in cancer. In this respect, due to the complex landscape of NONO activities and interactions, we highlight caveats that must be considered during experimental planning and data interpretation of NONO studies.  \nCancer Gene Therapy (2024) 31:984–994; [https://doi.org/10.1038/s41417-024-00763-x](https://doi.org/10.1038/s41417-024-00763-x)  \nINTRODUCTION  \nNONO (NONO/p54nrb, or non-POU domain-containing octamerbinding protein) is a member of the Drosophila behavior/human splicing (DBHS) family of proteins, together with the splicing factor proline-/glutamine-rich (SFPQ) and the paraspeckle protein component 1 (PSPC1) [1] .  \nNONO is a multifunctional protein with numerous roles in genome maintenance and gene regulation [1, 2] . It is mainly located within the nucleus of most mammalian cells; however, under different conditions, it can be triggered by binding to local high concentrations of various nucleic acids to form microscopically visible nuclear bodies, paraspeckles (PSs) or large complexes such as DNA repair foci [1] . In particular, NONO is an essential structural component of PSs, which are dynamic organelles that regulate different cellular functions, including mRNA nuclear retention, micro-RNA processing, DNA damage repair (DDR) systems regulation, stress response, and act as a molecular sponge for RNA binding proteins [3] .  \nThe NONO protein has two N-terminal RNA recognition motifs (RRM), a NONA/paraspeckle domain (NOPS), a coiled-coil at the C-terminus, and N- and C-terminal intrinsically disordered low complexity domains [1, 4] . Structural and biological data regarding NONO suggest that it rarely operates as a single molecule; rather it forms heterodimers with the other DBHS proteins, which can bind DNA and RNA, and mediates additional protein–protein interactions [4, 5] . Furthermore, NONO undergoes liquid–liquid phase separation, a process in which  \nmacromolecules such as proteins or nucleic acids condense into a dense phase that often resembles liquid droplets, and this dense phase coexists with the dilute phase; this phenomenon explains the dynamic association of molecules into membraneless organelles, or condensates [6–9] . Indeed, both PSs and DNA damage foci are now classiﬁed as condensates built upon liquid–liquid phase separation properties of various protein components, including NONO [9–11] . Recently, it has been reported that phase separation promoted by NONO can play an important role also in gene regulation [12] .  \nSeveral stu","cbCairucqBs82A6T","https://ap.wps.com/l/cbCairucqBs82A6T","pdf",2955676,11,"English","# Introduction\n## NONO as a DBHS family protein\n## Nuclear localization, paraspeckles, and condensates\n## Structural domains and interaction networks\n## Gene regulation mechanisms involving NONO\n# Tumorigenesis and implications for cancer research","[{\"question\":\"What biological functions does NONO regulate in cells?\",\"answer\":\"NONO regulates diverse processes including gene regulation, cell proliferation, apoptosis, migration, and DNA damage repair. It also contributes to maintaining cellular circadian rhythm coupled to the cell cycle.\"},{\"question\":\"How does NONO contribute to gene regulation at the molecular level?\",\"answer\":\"NONO participates in nearly every step of gene regulation, including mRNA splicing, transcription activation and termination, DNA unwinding, and nuclear retention of defective RNA. It binds both chromatin regulatory elements and intronic regions of pre-mRNAs.\"},{\"question\":\"Why is NONO considered relevant to cancer and therapeutic targeting?\",\"answer\":\"Altered NONO expression levels are associated with tumorigenesis, and NONO can be modified post-transcriptionally or post-translationally in ways whose cancer impact is still being clarified. The review proposes NONO as a potential therapeutic target while emphasizing caveats for experimental design and data interpretation.\"}]","The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers | PDF",1790042424,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb0e55a8156a9494ec157b2b2a6c976e.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1441c1b6bc4c1c173e1c082fa972b77f.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ff84f44608ed3560a29f17df3a87b85.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef62b75b0a36ca10d3197a3c864ee0a8.webp",980,1301]